PureTech News

Press releases
Press Releases - 2022-05-17
PureTech to Present at the UBS Global Healthcare Conference
Press Releases - 2022-05-16
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-100
PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
Press Releases - 2022-05-09
PureTech Announces Share Buyback Programme Update
Press Releases - 2022-05-05
PureTech Announces Share Buyback Programme of up to $50 million
Press Releases - 2022-05-04
PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
Press Releases - 2022-04-29
PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
Press Releases - 2022-04-26
PureTech Announces Annual Results for Year Ended December 31, 2021
Press Releases - 2022-04-13
PureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 Results
Press Releases - 2022-04-12
PureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults with Major Depressive Disorder When Combined with Antidepressant Medication
Press Releases - 2022-04-12
Wholly Owned Pipeline - Technology Platforms
PureTech Announces Publication of Research from Collaborators Demonstrating PureTech's Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)
Displaying 51 - 60 of 342

Sign up for email alerts

To receive news as it is released, please sign up.